Hopp til hovedinnholdet

Publications

NIBIOs employees contribute to several hundred scientific articles and research reports every year. You can browse or search in our collection which contains references and links to these publications as well as other research and dissemination activities. The collection is continously updated with new and historical material.

2023

To document

Abstract

Plants provide not only food and feed, but also herbal medicines and various raw materials for industry. Moreover, plants can be green factories producing high value bioproducts such as biopharmaceuticals and vaccines. Advantages of plant-based production platforms include easy scale-up, cost effectiveness, and high safety as plants are not hosts for human and animal pathogens. Plant cells perform many post-translational modifications that are present in humans and animals and can be essential for biological activity of produced recombinant proteins. Stimulated by progress in plant transformation technologies, substantial efforts have been made in both the public and the private sectors to develop plant-based vaccine production platforms. Recent promising examples include plant-made vaccines against COVID-19 and Ebola. The COVIFENZ® COVID-19 vaccine produced in Nicotiana benthamiana has been approved in Canada, and several plant-made influenza vaccines have undergone clinical trials. In this review, we discuss the status of vaccine production in plants and the state of the art in downstream processing according to good manufacturing practice (GMP). We discuss different production approaches, including stable transgenic plants and transient expression technologies, and review selected applications in the area of human and veterinary vaccines. We also highlight specific challenges associated with viral vaccine production for different target organisms, including lower vertebrates (e.g., farmed fish), and discuss future perspectives for the field.

To document

Abstract

Chlorella vulgaris is a freshwater microalga that synthesises large amounts of saturated lipids, which makes it suitable for production of bioenergy and biofuels. Since its cultivation usually requires freshwater, it competes with agriculture, economic development and ecological conservation for this limited natural resource. This study investigated the possibility of the partial replacement of freshwater by seawater (50 %) in the growth medium for a more sustainable biomass and lipid production. Chlorella vulgaris 211-11b was cultivated as shake-flask cultures in Bold's Basal Medium (BBM) formulated with 50 % freshwater and 50 % seawater under photoautotrophic, mixotrophic and heterotrophic conditions for eight days with glucose as organic carbon source in the latter two cases. The alga's best growth performance and highest lipid contents (49 % DW−1), dominated by palmitioleic and oleic acid, occurred under mixotrophic rather than photoautotrophic and heterotrophic conditions. This study demonstrates a more economic and ecologically sustainable biomass and lipid production of C. vulgaris by saving 50 % freshwater, which is available for other purposes.